Finance

Lists
002653:SHE
Haisco Pharmaceutical Group Co Ltd
CN¥56.78
+1.39%
(+0.78) 1D
Oct 16, 3:04:21 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002653...
Open
CN¥56.99
High
CN¥59.50
Low
CN¥55.88
Mkt. cap
68.25B
Avg. vol.
4.58M
Volume
3.98M
Dividend
1.16%
Quarterly dividend
CN¥0.16
Ex-dividend date
Sep 4, 2026
P/E ratio
64.76
52-wk high
CN¥80.83
52-wk low
CN¥42.38
EPS
CN¥0.88
Shares outstanding
1.14B
No. of employees
6K
Open
CN¥56.99
High
CN¥59.50
Low
CN¥55.88
Mkt. cap
68.25B
Avg. vol.
4.58M
Volume
3.98M
Dividend
1.16%
Quarterly dividend
CN¥0.16
Ex-dividend date
Sep 4, 2026
P/E ratio
64.76
52-wk high
CN¥80.83
52-wk low
CN¥42.38
EPS
CN¥0.88
Shares outstanding
1.14B
No. of employees
6K
News stories
From web sources and news partners
About Haisco Pharmaceutical Group Co Ltd
CEO-
Employees5.6K
Founded2000
Headquarters-
SectorPharmaceutical industry
Websitehaisco.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.30B
1.09B
1.56B
1.53B
Cost of goods sold
320.07M
405.00M
290.96M
321.55M
Cost of revenue
320.07M
405.00M
290.96M
321.55M
Research and development expenses
200.61M
261.90M
225.24M
353.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
575.61M
590.48M
472.75M
581.09M
Operating expense
791.42M
859.43M
706.43M
951.23M
Total operating expenses
1.11B
1.26B
997.39M
1.27B
Operating income
187.81M
-176.78M
566.60M
258.83M
Other non operating income
-21.33M
23.71M
-2.33M
1.64M
EBT including unusual items
189.78M
-64.13M
592.93M
279.97M
EBT excluding unusual items
165.82M
-155.42M
565.01M
254.88M
Income tax expense
23.30M
-28.41M
38.33M
-16.64M
Effective tax rate
12.28%
44.30%
6.46%
-5.94%
Other operating expenses
12.38M
9.94M
10.01M
15.95M
Net income
166.48M
-35.72M
554.61M
296.62M
Net profit margin
12.81%
-3.28%
35.46%
19.37%
Earnings per share
-
-
-
-
Interest and investment income
7.04M
6.36M
7.50M
9.97M
Interest expense
-8.05M
-7.63M
-6.76M
-7.06M
Net interest expenses
-1.01M
-1.27M
741.96K
2.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
246.89M
-111.07M
632.30M
335.93M
Gain or loss from assets sale
-289.14K
22.27M
-
-877.19K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps